KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Net Cash Flow (2016 - 2025)

Zimmer Biomet Holdings has reported Net Cash Flow over the past 17 years, most recently at -$701.6 million for Q4 2025.

  • Quarterly results put Net Cash Flow at -$701.6 million for Q4 2025, down 2651.37% from a year ago — trailing twelve months through Dec 2025 was $47.4 million (down 62.62% YoY), and the annual figure for FY2025 was $47.4 million, down 62.62%.
  • Net Cash Flow for Q4 2025 was -$701.6 million at Zimmer Biomet Holdings, down from $739.2 million in the prior quarter.
  • Over the last five years, Net Cash Flow for ZBH hit a ceiling of $852.2 million in Q1 2025 and a floor of -$842.4 million in Q2 2025.
  • Median Net Cash Flow over the past 5 years was -$20.6 million (2023), compared with a mean of -$3.7 million.
  • Peak annual rise in Net Cash Flow hit 5083.63% in 2025, while the deepest fall reached 2861.97% in 2025.
  • Zimmer Biomet Holdings' Net Cash Flow stood at -$442.2 million in 2021, then skyrocketed by 58.91% to -$181.7 million in 2022, then skyrocketed by 163.95% to $116.2 million in 2023, then tumbled by 121.94% to -$25.5 million in 2024, then tumbled by 2651.37% to -$701.6 million in 2025.
  • The last three reported values for Net Cash Flow were -$701.6 million (Q4 2025), $739.2 million (Q3 2025), and -$842.4 million (Q2 2025) per Business Quant data.